Results 171 to 180 of about 54,072 (237)

Towards an Integrated Staging Model for Bipolar Disorders: An International Society for Bipolar Disorders (ISBD) Staging Task Force Consensus Report

Bipolar Disorders, Volume 28, Issue 5, August 2026.
ABSTRACT Objectives Three clinical staging models for bipolar disorder (BD) have been published, each with a different but complementary approach and focus. The International Society for Bipolar Disorders Staging Task Force aimed to integrate these models into one comprehensive three‐dimensional staging model, separately rating bipolar spectrum ...
Ralph Kupka, Danella Hafeman, Madeleine McCallum, Afra van der Markt, Hailey Tremain, Martin Alda, Jorge Almeida, Taiane de Azevedo Cardoso, Vicent Balanzá‐Martínez, Boris Birmaher, David J. Bond, Elisa Brietzke, Ines Chendo, Iria Grande, Tomas Hajek, Manon Hillegers, Marcia Kauer‐Sant'Anna, Rodrigo Mansur, Ives Cavalcante Passos, Ana Gonzalez Pinto, Robert Post, Mauricio Tohen, Gustavo Vazquez, Eduard Vieta, Lakshmi N. Yatham, Flávio Kapczinski, Michael Berk, Anne Duffy   +27 more
wiley   +1 more source

Ética de la investigación biomédica

Arbor: Ciencia, Pensamiento y Cultura, 2008
David Rodríguez-Arias
doaj  

Correction: Real-world adherence trajectories to direct oral anticoagulants in naive patients with atrial fibrillation in Spain. [PDF]

Front Pharmacol
Leguízamo-Martínez LM, Ballarin ME, Hurtado I, Sanfélix-Gimeno G, Sánchez-Sáez F, Sabaté M.   +5 more
europepmc   +1 more source

ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

International Journal of Cancer, Volume 159, Issue 2, Page 410-422, 15 July 2026.
What's new? Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic precursor to multiple myeloma, sharing substantial genetic features with overt malignancy. Given evidence implicating autophagy in myeloma risk, this study examined whether genetic variations in autophagy‐related genes influence MGUS susceptibility.
José Manuel Sánchez‐Maldonado, Angelica Macauda, Antonio José Cabrera‐Serrano, Hauke Thomsen, Murat Güler, Rob Ter Horst, Bethany van Guelpen, Pavel Vodicka, Stefano Landi, Subhayan Chattopadhyay, Pelin Ünal, Lucía Ruiz‐Durán, Delphine Casabonne, Hartmut Goldschmidt, Istemi Serin, María Carretero‐Fernández, Elena Cabezudo, Fernando Reyes‐Zurita, Aaron D. Norman, Ramón García‐Sanz, Gabriele Capurso, Per Hoffmann, Ulrika Pettersson‐Kymmer, Francisco Jiménez‐Romera, S. Vincent Rajkumar, Niels Weinhold, Ludmila Vodickova, Christian Langer, Angelika Stein, Abdulkadir Karismaz, Victor Moreno, Markus M. Nöthen, Karl‐Heinz Jöckel, Francesca Tavano, Joaquín Martínez‐López, Shaji K. Kumar, Juan Francisco Gutiérrez‐Bautista, Daniela Basso, Florentin Späth, Yolanda Benavente, Michelle A. T. Hildebrandt, Börge Schmidt, Tereza Sevcikova, Rui Manuel Vieira Reis, Yang Li, Miguel Ángel López‐Nevot, Mihai G. Netea, Daniele Campa, Alyssa Clay‐Gilmour, Susan L Slager, Kari Hemminki, Celine M Vachon, Asta Försti, Federico Canzian, Juan Sainz   +54 more
wiley   +1 more source

Erratum for Recacha et al., "Characterization of a <i>bla</i>_KPC-3-carrying plasmid in a clinical isolate of <i>Klebsiella pneumoniae</i> belonging to the emerging successful clone ST147". [PDF]

Microbiol Spectr
Recacha E, Delgado-Valverde M, Pulido MR, Pérez-Nadales E, Pérez-Palacios P, Portillo-Calderón I, Sánchez-Calvo JM, Gracia-Ahufinger I, Pascual Á.   +8 more
europepmc   +1 more source

Adaptation of the International Consortium for Health Outcomes Measurement Standard Set for Inflammatory Bowel Disease for Routine Collection in Clinical Practice

JCC Plus, Volume 1, Issue 4, July 2026.
ABSTRACT Background and Aims Value‐based healthcare (VBHC) is based on evaluating clinical interventions according to their ability to improve outcomes and costs to finally enhance quality of care. As part of an initiative to introduce VBHC in inflammatory bowel disease (IBD), our project aimed to adapt the International Consortium for Health Outcomes ...
Xavier Calvet, Iago Rodríguez‐Lago, Jose‐Lázaro Pérez‐Calle, Hugo Bronchalo‐Bautista, Elena Barbazán‐García, on behalf of the EEImprove Collaborative Project TEam, Alberto Vegas‐Miguel, Alicia Diaz‐Redondo, Ane Fullaondo‐Zabala, Carles Illa, Celia Albaladejo Blanco, Daniel Ceballos, Ignacio Marín‐Jiménez, Jesus Barrio Andres, Jesús Gonzalo Gómez Gómez, Jone Ortiz de Zaarate Sagastagoitia, Juan Manuel Sánchez Lledó, Laura Gómez‐Irwin, Luis Alberto Menchen Viso, Maite Zabala Ugarteburu, María Carme Nicolás Herrerías, María Dolores Martín‐Arranza, María Esteve Comas, María Mercedes Ortiz Otero, Mirari San Felix Carrasco, Mónica Sierra‐Ausin, Monsterrat Aceituno Quintanilla, Olga Merino Ochoa, Pilar López Serrano, Raúl Martín Puentes, San José Fernando Bermejo, Susana Castelo Zas, Susana Lorenzo Martínez, Yamile Zabana   +33 more
wiley   +1 more source

Erratum to "Exploring the universal healthy human gut microbiota around the World". [PDF]

Comput Struct Biotechnol J
Piquer-Esteban S, Ruiz-Ruiz S, Arnau V, Diaz W, Moya A.   +4 more
europepmc   +1 more source

Nutritional characterization of Cusco green tea and its synergistic effect with omega‐3 on metabolic and cognitive dysfunctions in obese rats

Journal of the Science of Food and Agriculture, Volume 106, Issue 9, Page 5643-5657, July 2026.
Abstract BACKGROUND Obesity and its metabolic complications, such as insulin resistance and cognitive decline, remain a global health challenge. Green tea (Camelia sinensis) and ω‐3 polyunsaturated fatty acids (PUFAs) are recognized for their antioxidant, anti‐inflammatory, and neuroprotective properties.
Paola Finetti‐Casanova, Nataly Bernuy‐Osorio, Miguel Rodriguez‐Pozo, Aya Maaloul, Roberto T Abdala‐Diaz, Juan Decara   +5 more
wiley   +1 more source

Dietary Choline and Betaine Intake and 2-year Changes in Cognitive Function in Older Adults With Overweight or Obesity and Metabolic Syndrome: A Prospective Cohort Analysis. [PDF]

Am J Clin Nutr
Vázquez-Lorente H, Manzanares-Errazu JM, Babio N, Ruiz-Canela M, Corella D, Hernando J, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Urbano-Fernández V, Serra-Majem L, Cano-Ibáñez N, Tur JA, Sánchez VM, Pintó X, Delgado-Rodríguez M, Matía-Martín P, Vidal J, Vázquez C, Ros E, Fernández-Aranda F, Toledo E, Gutiérrez-Carrasquilla L, Sorlí JV, Zomeño MD, Garcia-Rios A, Oncina-Canovas A, Cueto-Galán R, Zulet MA, Prohens L, Casas R, Durán-Luque M, Tojal-Sierra L, Simón-Frapolli V, Vázquez-Ruiz Z, Fernández-Carrión R, Castañer O, Rodriguez-Mancheño AL, Asencio A, García-Arellano A, Fitó M, Daimiel L, Salas-Salvadó J.   +47 more
europepmc   +1 more source

Regulación internacional de los comités de ética en investigación biomédica como mecanismos de protección de las personas: Análisis del Protocolo Adicional sobre Investigación Biomédica al Convenio sobre Derechos Humanos y Biomedicina del Consejo de Europa

El artículo sistematiza y analiza el contenido del Protocolo Adicional sobre Investigación Biomédica al Convenio sobre Derechos Humanos y Biomedicina del Consejo de Europa, como instrumento jurídico de referencia en investigación biomédica, promulgado ...
Lecuona Ramírez, Itziar de
core